Design, synthesis and biological evaluation of imidazo[1,5-a]pyridine–PBD conjugates as potential DNA-directed alkylating agents
- 27 November 2012
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 4 (4) , 697-703
Abstract
A series of novel imidazo[1,5-a]pyridine–PBD conjugates were synthesized and evaluated for their antitumor activity in breast cancer cell line (MCF-7). Interestingly, all the compounds showed enhanced DNA binding ability. These conjugates showed significant antitumor activity as deduced by MTT cell proliferation assay and amongst them, compounds 13f and 13g exhibit promising antitumor activity. G2/M phase cell cycle arrest was observed on the treatment of breast cancer cells (MCF-7) with 2 μM concentration of these compounds. Moreover, accumulation of cells in the G0 (apoptotic) phase was observed upon increase of their concentration to 4 μM. These compounds also induced the expression of proteins involved in apoptosis and DNA damage such as p53, p21 and γ-H2AX. In silico binding studies of compound 13g with DNA was performed to understand the mode of interactions and we observed that compound 13g binds well with the minor groove of DNA.Keywords
This publication has 51 references indexed in Scilit:
- Design and synthesis of benzo[c,d]indolone-pyrrolobenzodiazepine conjugates as potential anticancer agentsBioorganic & Medicinal Chemistry, 2012
- Design, synthesis, and biological evaluation of a novel series of bisintercalating DNA-binding piperazine-linked bisanthrapyrazole compounds as anticancer agentsBioorganic & Medicinal Chemistry, 2011
- Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazinesEuropean Journal of Medicinal Chemistry, 2011
- Discovery of a novel nitroimidazolyl–oxazolidinone hybrid with potent anti Gram-positive activity: Synthesis and antibacterial evaluationEuropean Journal of Medicinal Chemistry, 2011
- Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole–pyrrolobenzodiazepine conjugatesBioorganic & Medicinal Chemistry, 2010
- Synthesis and biological evaluation of anilino substituted pyrimidine linked pyrrolobenzodiazepines as potential anticancer agentsBioorganic & Medicinal Chemistry Letters, 2010
- Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activityBioorganic & Medicinal Chemistry Letters, 2010
- H2AX Is Required for Cell Cycle Arrest via the p53/p21 PathwayMolecular and Cellular Biology, 2009
- Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureusEuropean Journal of Medicinal Chemistry, 2008
- Synthesis of pyrrolo[2,1-c][1,4]benzodiazepines and their conjugates by azido reductive cyclization strategy as potential DNA-binding agentsBioorganic & Medicinal Chemistry Letters, 2005